Correlation of pretreatment 18F-FDG PET tumor textural features with gene expression in pharyngeal cancer and implications for radiotherapy-based treatment outcomes
Creators
- 1. China Medical University, Graduate Institute of Clinical Medical Science, School of Medicine, College of Medicine, Taichung (China)
- 2. Taipei Medical University, School of Medicine, Taipei (China)
- 3. China Medical University, School of Medicine, Taichung (China)
- 4. China Medical University Hospital, Department of Radiation Oncology, Taichung (China)
- 5. Asia University, Department of Computer Science and Information Engineering, Taichung (China)
- 6. China Medical University, Cancer Center and Department of Medical Research, China Medical University Hospital, Taichung (China)
- 7. China Medical University and Academia Sinica, The Ph.D. Program for Cancer Biology and Drug Discovery, Taichung (China)
- 8. China Medical University Hospital, Department of Pathology, Taichung (China)
- 9. China Medical University, Department of Biomedical Imaging and Radiological Science, Taichung (China)
- 10. China Medical University Hospital, Department of Nuclear Medicine and PET Center, Taichung (China)
- 11. Asia University, Department of Bioinformatics and Medical Engineering, Taichung (China)
Description
This study investigated the correlation of the matrix heterogeneity of tumors on 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) with gene-expression profiling in patients with pharyngeal cancer and determined the prognostic factors for radiotherapy-based treatment outcomes. We retrospectively reviewed the records of 57 patients with stage III-IV oropharyngeal or hypopharyngeal cancer who had completed definitive therapy. Four groups of the textural features as well as 31 indices were studied in addition to maximum standard uptake value, metastatic tumor volume, and total lesion glycolysis. Immunohistochemical data from pretreatment biopsy specimens (Glut1, CAIX, VEGF, HIF-1α, EGFR, Ki-67, Bcl-2, CLAUDIN-4, YAP-1, c-Met, and p16) were analyzed. The relationships between the indices and genomic expression were studied, and the robustness of various textural features relative to cause-specific survival and primary relapse-free survival was analyzed. The overexpression of VEGF was positively associated with the increased values of the matrix heterogeneity obtained using gray-level nonuniformity for zone (GLNUz) and run-length nonuniformity (RLNU). Advanced T stage (p = 0.01, hazard ratio [HR] = 3.38), a VEGF immunoreactive score of >2 (p = 0.03, HR = 2.79), and a higher GLNUz value (p = 0.04, HR = 2.51) were prognostic factors for low cause-specific survival, whereas advanced T stage, a HIF-1α staining percentage of ≥80%, and a higher GLNUz value were prognostic factors for low primary-relapse free survival. The overexpression of VEGF was associated with the increased matrix index of GLNUz and RLNU. For patients with pharyngeal cancer requiring radiotherapy, the treatment outcome can be stratified according to the textural features, T stage, and biomarkers. (orig.)
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00259-016-3580-5Additional details
Identifiers
Publishing Information
- Journal Title
- European Journal of Nuclear Medicine and Molecular Imaging
- Journal Volume
- 44
- Journal Issue
- 4
- Journal Page Range
- p. 567-580
- ISSN
- 1619-7070
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 48037919
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ANGIOGENESIS; CARCINOMAS; CELL PROLIFERATION; CHEMOTHERAPY; COMBINED THERAPY; COMPUTERIZED TOMOGRAPHY; CORRELATIONS; FLUORINE 18; FLUORODEOXYGLUCOSE; GENETICS; GLYCOLYSIS; MEGA BQ RANGE 100-1000; PHARYNX; POSITRON COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY; SENSITIVITY; SPECIFICITY; SURVIVAL CURVES; SURVIVAL TIME; TEXTURE; UPTAKE
- Descriptors DEC
- ANTIMETABOLITES; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BIOLOGY; BODY; CHEMICAL REACTIONS; COMPUTERIZED TOMOGRAPHY; DECOMPOSITION; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; FLUORINE ISOTOPES; HOURS LIVING RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MATERIALS; MEDICINE; MEGA BQ RANGE; METABOLISM; NANOSECONDS LIVING RADIOISOTOPES; NEOPLASMS; NUCLEAR MEDICINE; NUCLEI; ODD-ODD NUCLEI; ORGANS; RADIOACTIVE MATERIALS; RADIOACTIVITY RANGE; RADIOISOTOPES; RADIOLOGY; RESPIRATORY SYSTEM; THERAPY; TOMOGRAPHY